IBM heads into its July 22 earnings release with a stock that has rebounded strongly over the past month but pulled back slightly this week — and with a borrow market that offers almost no friction for new short sellers.
Note on pricing data: The snapshot captures IBM's ARS-listed shares, which carry a price of ARS 30,360. The narrative below draws on USD-denominated fundamentals and analyst context, which is the relevant frame for the US-listed stock.
The most striking feature of IBM's current setup is how little the lending market is signalling bearish conviction. Availability is loose — the data shows no meaningful squeeze pressure, with the utilization rank sitting in the 58th percentile and the short score ranking just 42nd out of the broader universe. For a company carrying this much short-seller history, that is a notably benign borrow environment. Short sellers are not crowding in ahead of what has historically been a tricky earnings print. Days-to-cover ranks in only the 20th percentile, meaning shorts could exit quickly if conditions shifted — another sign that current positioning is light rather than entrenched.
The options and momentum picture offers a modest counterpoint. EPS momentum over 30 days has held at a respectable 57th percentile, though the 90-day reading has slipped to 39, suggesting the near-term tape has been more supportive than the underlying estimate trend. The stock itself has gained 11.5% over the past month, yet it slipped 3.2% in the most recent week, leaving investors to weigh whether that retracement reflects genuine caution into earnings or simply a pause after a strong run. EPS surprise ranks in the 45th percentile — squarely average, not a stock that consistently blows estimates out.
The Street picture is mixed but not alarming. The dividend score ranks in the 98th percentile, underlining IBM's ongoing appeal to income-oriented holders. BlackRock holds 8.3% of shares and added nearly a million shares in the most recent reported period. State Street and JP Morgan Asset Management also added incrementally through mid-year. That institutional steady-hand picture contrasts with the softer fundamental momentum — analysts are broadly neutral in direction (analyst recommendation differential ranks 51st percentile), and the forward EPS growth score has faded to just the 11th percentile, meaning the Street collectively sees limited near-term earnings expansion. IBM's bull case rests on hybrid cloud and AI infrastructure demand; the bear case points to mainframe dependency, consulting margin pressure, and the risk that organic innovation remains subordinate to cost discipline.
The historical earnings record is worth noting plainly. IBM's last reported quarter — April 22 — saw the stock fall 8.8% in one session and 9.7% over the following five days. The April 28 event produced a more contained 2.2% one-day decline. That asymmetry — one sharp miss followed by a softer reaction — is the pattern IBM enters July 22 with, and it gives context to why positioning is defensive without being aggressive. The next session after the print will clarify whether the month-long rally was justified or simply front-ran a quarter that doesn't deliver.
What to watch from here is whether IBM's consulting and AI-infrastructure commentary sharpens the revenue outlook enough to push the 90-day EPS momentum score back toward neutral — or whether the combination of a light-short, loosely-borrowed setup and another disappointing print leaves the stock giving back more of its month-long gains than bulls currently expect.
See the live data behind this article on ORTEX.
Open IBM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
IBM enters May with an unusual dynamic: short sellers are quietly stepping back just weeks after the stock suffered one of its worst single-session earnings drops in recent memory. Q1 results on April 22 sent the stock…
IBM enters the back half of April nursing a sharp post-earnings wound — a 9.6% single-day drop on April 22 that analysts are still trying to price around. The week's central tension is straightforward: results…
